Inventor · disambiguated record
Constance L. Cepko
Also filed as: CEPKO CONSTANCE · CEPKO CONSTANCE L · CEPKO CONSTANCE LOUISE
9 granted patents·10 pending applications·87 citations·filing 1982–2024
81Inventor score
Files withHARVARD COLLEGE13CEPKO CONSTANCE L2BROAD INST INC1CEPKO CONSTANCE LOUISE1MASSACHUSETTS INST TECHNOLOGY1
Top patents by PatentIndex Score
19 records- 0188US4487829AProduction and use of monoclonal antibodies against adenovirusesMASSACHUSETTS INST TECHNOLOGY·Filed 1982·Granted Dec 11, 1984·82 cites·15 claims
- 0282US11225689B2Method for determination and identification of cell signatures and cell markersBROAD INST INC·Filed 2017·Granted Jan 18, 2022·4 cites·12 claims
- 0377US2024350673A1Methods and compositions for inhibiting oxidative stressHARVARD COLLEGE·Filed 2024·Application pending·0 cites
- 0473US10980896B2Methods and compositions for inhibiting oxidative stressHARVARD COLLEGE·Filed 2014·Granted Apr 20, 2021·1 cites·7 claims
- 0567US12042546B2Methods and compositions for inhibiting oxidative stressHARVARD COLLEGE·Filed 2021·Granted Jul 23, 2024·0 cites·9 claims
- 0664US2024175051A1Cd47 compositions and methods for the treatment of degenerative ocular diseasesHARVARD COLLEGE·Filed 2023·Application pending·0 cites
- 0758US2009281163A1Regulatory elements that mediate retinal cell-specific gene expressionHARVARD COLLEGE·Filed 2008·Application pending·0 cites
- 0854US8912153B2HDAC4 nucleic acid administration to treat retinal diseaseCEPKO CONSTANCE L·Filed 2009·Granted Dec 16, 2014·0 cites·20 claims
- 0954US2023398235A1Variant txnip compositions and methods of use thereof for the treatment of degenerative ocular diseasesHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 1053US2023277685A1TGFß THERAPY FOR OCULAR AND NEURODEGENERATIVE DISEASESHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 1152US11827926B2Methods and compositions for the diagnosis and treatment of COVID 19HARVARD COLLEGE·Filed 2021·Granted Nov 28, 2023·0 cites·20 claims
- 1249US2011318424A1METHODS FOR PROLONGING VIABILITY OF CONE CELLS USING MODULATORS OF THE MAMMALIAN TARGET OF RAPAMYCINE (mTOR)CEPKO CONSTANCE LOUISE·Filed 2009·Application pending·0 cites
- 1348US2022118107A1Txnip and ldhb compositions and methods for the treatment of degenerative ocular diseasesHARVARD COLLEGE·Filed 2020·Application pending·0 cites
- 1445US2022088222A1Compositions and methods for the treatment of degenerative ocular diseasesHARVARD COLLEGE·Filed 2019·Application pending·0 cites
- 1541US2016235826A1Histone deacetylase compositions and uses thereofHARVARD COLLEGE·Filed 2014·Application pending·0 cites
- 1640US9949464B2Target molecules for transcriptional control systemsHARVARD COLLEGE·Filed 2014·Granted Apr 24, 2018·0 cites·14 claims
- 1733US2013230863A1Target Molecules for Transcriptional Control SystemsTANG CHUNG YIU JONATHAN·Filed 2013·Application pending·0 cites
- 1832US11267874B2Sensor systems for target ligands and uses thereofHARVARD COLLEGE·Filed 2016·Granted Mar 8, 2022·0 cites·16 claims
- 1925US9610363B2Methods for inhibiting starvation of a cellCEPKO CONSTANCE L·Filed 2010·Granted Apr 4, 2017·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Constance L. Cepko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →